Опыт лечения первичной дисфункции трансплантата после трансплантации сердца

Трансплантация сердца – кардиохирургическая операция, в результате которой патологически измененное сердце реципиента заменяется на удовлетворительно функционирующее сердце донора. Как и любое хирургическое вмешательство, трансплантация сердца несет в себе риск осложнений, и одним из таких является первичная дисфункция трансплантата. В этом сообщении мы рассказываем о первом опыте диагностики и лечения пациента с первичной дисфункцией трансплантата, потребовавшей механической поддержки кровообращения.

1. Клинические рекомендации. Трансплантация сердца, наличие трансплантированного сердца, отмирание и отторжение трансплантата сердца. Министерство здравоохранения РФ. 2023.

2. Russo MJ, Iribarne A, Hong KN, Ramlawi B, Chen JM, Takayama H et al. Factors associated with primary graft failure after heart transplantation. Transplantation. 2010; 90 (4): 444–450. https://doi.org/10.1097/TP.0b013e3181e6f1eb.

3. Dronavalli VB, Rogers CA, Banner NR. Primary Cardiac Allograft Dysfunction-Validation of a Clinical Definition. Transplantation. 2015; 99 (9): 1919–1925. https://doi.org/10.1097/TP.0000000000000620.

4. D’Alessandro C, Aubert S, Golmard JL, Praschker BL, Luyt CE, Pavie A et al. Extra-corporeal membrane oxygenation temporary support for early graft failure after cardiac transplantation. European journal of cardio-thoracic surgery: official journal of the European Association for Cardio-thoracic Surgery. 2010; 37 (2): 343–349. https://doi.org/10.1016/j.ejcts.2009.05.034.

5. Oto T, Excell L, Griffiths AP, Levvey BJ, Bailey M, Marasco S et al. Association between primary graft dysfunction among lung, kidney and heart recipients from the same multiorgan donor. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2008; 8 (10); 2132–2139. https://doi.org/10.1111/j.1600-6143.2008.02357.x.

6. Ibrahim M, Hendry P, Masters R, Rubens F, Lam BK, Ruel M et al. Management of acute severe perioperative failure of cardiac allografts: a single-centre experience with a review of the literature. The Canadian journal of cardiology. 2007; 23 (5): 363–367. https://doi.org/10.1016/s0828-282x(07)70769-9.

7. Kobashigawa J, Zuckermann A, Macdonald P, Leprince P, Esmailian F, Luu M et al. Consensus Conference participants. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. 2014; 33 (4): 327–340. https://doi.org/10.1016/j.healun.2014.02.027.

8. Subramani S, Aldrich A, Dwarakanath S, Sugawara A, Hanada S. Early Graft Dysfunction Following Heart Transplant: Prevention and Management. Seminars in Cardiothoracic and Vascular Anesthesia. 2020; 24 (1): 24–33. doi: 10.1177/1089253219867694.

9. Hull TD, Crowley JC, Villavicencio MA, D’Alessandro DA. Primary graft dysfunction in heart transplantation: How to recognize it, when to institute extracorporeal membrane oxygenation, and outcomes. JTCVS Open. 2021 May 27; 8: 128–133. doi: 10.1016/j.xjon.2021.05.010. PMID: 36004187; PMCID: PMC9390270.

10. Sabatino M, Vitale G, Manfredini V, Masetti M, Borgese L, Maria Raffa G et al. Clinical relevance of the International Society for Heart and Lung Transplantation consensus classification of primary graft dysfunction after heart transplantation: Epidemiology, risk factors, and outcomes. The Journal of heart and lung transplantation: the official publication of the International Society for Heart Transplantation. 2017; 36 (11): 1217–1225. https://doi.org/10.1016/j.healun.2017.02.014.

11. Jacob S, Lima B, Gonzalez-Stawinski GV, El-Sayed Ahmed MM, Patel PC, Belli EV et al. Extracorporeal membrane oxygenation as a salvage therapy for patients with severe primary graft dysfunction after heart transplant. Clinical transplantation. 2019; 33 (5): e13538. https://doi.org/10.1111/ctr.13538.

12. Wernovsky G, Wypij D, Jonas RA, Mayer JE Jr, Hanley FL, Hickey PR et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation. 1995; 92 (8): 2226–2235. https://doi.org/10.1161/01.cir.92.8.2226.

13. Gaies MG, Gurney JG, Yen AH, Napoli ML, Gajarski RJ, Ohye RG et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2010; 11 (2): 234–238. https://doi.org/10.1097/PCC.0b013e3181b806fc.

14. Favia I, Vitale V, Ricci Z. The vasoactive-inotropic score and levosimendan: Time for LVIS? J Cardiothorac Vasc Anesth. 2013; 27: e15–e16. doi: 10.1053/j.jvca.2012.11.009.

15. Caruso V, Berthoud V, Bouchot O, Nguyen M, Bouhemad B, Guinot PG. ECMOVIS Study Group. Should the Vasoactive Inotropic Score be a Determinant for Early Initiation of VA ECMO in Postcardiotomy Cardiogenic Shock? J Cardiothorac Vasc Anesth. 2024 Mar; 38 (3): 724–730. doi: 10.1053/j.jvca.2023.11.040. Epub 2023 Dec 1. PMID: 38182434.

16. Hyun J, Kim AR, Lee SE, Hong JA, Kang PJ, Jung SH, Kim MS. Vasoactive-Inotropic Score as a Determinant of Timely Initiation of Venoarterial Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock. Circ J. 2022 Mar 25; 86 (4): 687–694. doi: 10.1253/circj.CJ-21-0614. Epub 2021 Nov 9. PMID: 34759121.

17. Leprince P, Aubert S, Bonnet N, Rama A, Léger P, Bors V et al. Peripheral extracorporeal membrane oxygenation (ECMO) in patients with posttransplant cardiac graft failure. Transplantation proceedings. 2005; 37 (6): 2879–2880. https://doi.org/10.1016/j.transproceed.2005.05.018.

18. Taghavi S, Zuckermann A, Ankersmit J, Wieselthaler G, Rajek A, Laufer G et al. Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. The Annals of thoracic surgery. 2004; 78 (5): 1644–1649. https://doi.org/10.1016/j.athoracsur.2004.04.059.

19. Thongprayoon C, Lertjitbanjong P, Hansrivijit P, Crisafio A, Mao MA, Watthanasuntorn K et al. Acute Kidney Injury in Patients Undergoing Cardiac Transplantation: A Meta-Analysis. Medicines (Basel). 2019 Nov 1; 6 (4): 108. doi: 10.3390/medicines6040108. PMID: 31683875; PMCID: PMC6963309.

20. Поз ЯЛ, Строков АГ, Попцов ВН, Шевченко АО, Готье СВ. Патогенетические механизмы, эпидемиология и классификация острого повреждения почек у реципиентов сердечного трансплантата. Вестник трансплантологии и искусственных органов. 2021; 23 (2): 147–157. https://doi.org/10.15825/1995-1191-2021-2-147-157.

21. Kidney disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter Suppl. 2012; 2: 1–138. doi: 10.1038/kisup.2012.1.

22. Ostermann M, Connor M Jr, Kashani K. Continuous renal replacement therapy during extracorporeal membrane oxygenation: why, when and how? Current opinion in critical care. 2018; 24 (6): 493–503. https://doi.org/10.1097/MCC.0000000000000559.

23. Поз ЯЛ, Строков АГ, Копылова ЮВ, Попцов ВН, Готье СВ. Заместительная почечная терапия у реципиентов сердечного трансплантата. Вестник трансплантологии и искусственных органов. 2021; 23 (4): 62–72. https://doi.org/10.15825/1995-1191-2021-4-62-72.

24. Ajibowo AO, Okobi OE, Emore E, Soladoye E, Sike CG, Odoma VA et al. Cardiorenal Syndrome: A Literature Review. Cureus. 2023 Jul 1; 15 (7): e41252. doi: 10.7759/cureus.41252. PMID: 37529809; PMCID: PMC10389294.